Mitogenic estrogen metabolites alter the expression of 17β-estradiol- regulated proteins including heat shock proteins in human MCF-7 breast cancer cells

Molecules and Cells

Volumn 20, Issue 3, 2005, Pages 378-384

  Kim, Seong Hwan ^a   Lee, Su Ui ^a   Kim, Myung Hee ^a   Kim, Bum Tae ^a   Min, Yong Ki ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

16 Hydroxyestrone; 17 Estradiol; 2 Hydroxyestradiol; 2 Methoxyestradiol; 4 Hydroxyestradiol; Breast Cancer; Heat Shock Proteins

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; 4 HYDROXYESTRADIOL; AMINOACYLASE; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 56; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 90 ALPHA; PROGESTERONE RECEPTOR; PROTEIN DISULFIDE ISOMERASE; STATHMIN; UNCLASSIFIED DRUG; AMIDASE; AMINOACYLASE I; CHAPERONIN; DRUG DERIVATIVE; FK 506 BINDING PROTEIN; HEAT SHOCK PROTEIN 90; MESSENGER RNA; MITOGENIC AGENT; STMN1 PROTEIN, HUMAN; TACROLIMUS BINDING PROTEIN 4;

ARTICLE; BREAST CANCER; CANCER CELL; HUMAN; METABOLITE; MITOGENESIS; PROTEIN EXPRESSION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MINK CELL FOCUS-FORMING VIRUS;

AMIDOHYDROLASES; BREAST NEOPLASMS; CHAPERONIN 60; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MITOGENS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATHMIN; TACROLIMUS BINDING PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33644871957     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.42-3-378     Document Type: Article

References (44)

1. Balabanov, S., Zimmermann, U., Protzel, C., Scharf, C., Klebingat, K. J., et al. (2001) Tumor-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur. J. Biochem. 268, 5977-5980.
2. Beliakoff, J. and Whitesell, L. (2004) Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs 15, 651-662.
3. Cappello, F., Bellafiore, M., Palma, A., David, S., Marciano, V., et al. (2003) 60 Kda chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur. J. Histochem. 47, 105-110.
4. Cappello, F., Bellafiore, M., Palma, M. A., Marciano, V., Martorana, G., et al. (2002-2003) Expression of 60-kDa heat shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology 70, 83-88.
5. Clemons, M. and Goss, P. (2001) Estrogen and the risk of breast cancer. N. Engl. J. Med. 344, 276-285.
6. Cook, R. M., Franklin, W. A., Moore, M. D., Johnson, B. E., and Miller, Y. E. (1998) Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line. Genes Chromosomes Cancer 21, 320-325.
7. Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z., and Nardai, G. (1998) The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129-168.
8. Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Gonthier, M. P., et al. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82, 142-150.
9. Darbre, P., Yates, J., Curtis, S., and King, R. J. (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43, 349-354.
10. Ernst, M., Schmid, C., and Froesch, E. R. (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. Steroid Biochem. 33, 907-914.
11. Fishman, J. and Martucci, C. (1980) Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin. Endocrinol Metab. 51, 611-615.
12. Fishman, J., Schneider, J., Hershcope, R. J., and Bradlow, H. L. (1984) Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. Steroid Biochem. 20, 1077-1081.
13. Flouriot, G., Brand, H., Denger, S., Metivier, R., Kos, M., et al. (2000) Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19, 4688-4700.
14. Frydman, J. and Hart, F. U. (1996) Principles of chaperone-assisted protein folding: differences between in vitro and in vivo mechanisms. Science 272, 1497-1502.
15. Gupta, M., McDougal, A., and Safe, S. (1998) Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67, 413-419.
16. Horwitz, K. B. and McGuire, W. L. (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253, 2223-2228.
17. Hwang, T. S., Han, H. S., Choi, H. K., Lee, Y. J., Kim, Y. J., et al. (2003) Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol. 18, 690-700.
18. Isaacs, J. S., Xu, W., and Neckers, L. (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3, 213-217.
19. Kim, S. H., Lee, S., Kim, M. H., Kim, B. T., and Min, Y. K. (2005) Protein profiling and transcript expression levels of heat shock proteins in 17β-estradiol-treated human MCF-7 breast cancer cells, (submitted).
20. Kumar, P., Mark, P. J., Ward, B. K., Minchin, R. F., and Ratajczak, T. (2001) Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225.
21. Lewis, J. S., Thomas, T. J., Klinge, C. M., Gallo, M. A., and Thomas, T. (2001) Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells. J. Mol. Endocrinol. 27, 293-307.
22. Li, J. J. and Li, S. A. (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 46, 1858-1863.
23. Liehr, J. G. and Ricci, M. J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA 93, 3294-3296.
24. Liehr, J. G., Fang, W. F., Sirbasku, D. A., and Ari-Ulubelen, A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356.
25. Lippert, T. H., Seeger, H., and Mueck, A. O. (2000) The impact of endogenous estradiol metabolites on carcinogenesis. Steroids 65, 357-369.
26. Lippert, C., Seeger, H., and Mueck, A. O. (2003) The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci. 72, 877-883.
27. Liu, Z. J. and Zhu, B. T. (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J. Steroid Biochem. Mol. Biol. 88, 265-275.
28. T method. Methods 25, 402-408.
29. Lorenzo, J. (2003) A new hypothesis for how sex steroid hormones regulate bone mass. J. Clin. Invest. 111, 1641-1643.
30. McGuire, W. L., Horwitz, K. B., Chamness, G. C., and Zava, D. T. (1976) A physiological role for estrogen and progesterone in breast cancer. J. Steroid Biochem. 7, 875-882.
31. Nardulli, A. M., Greene, G. L., O'Malley, B. W., and Katzenellenbogen, B. S. (1988) Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 122, 935-944.
32. Newbold, R. R. and Liehr, J. G. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60, 235-237.
33. Oh, W. K. and Song, J. (2003) Cooperative interaction of Hsp40 and TPR1 with Hsp70 reverses Hsp70-HspBp1 complex formation. Mol. Cells 16, 84-91.
34. Peattie, D. A., Harding, M. W., Fleming, M. A., DeCenzo, M. T., Lippke, J. A., et al. (1992) Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. USA 89, 10974-10978.
35. Rogan, E. G., Badawi, A. F., Devanesan, P. D., Meza, J. L., Edney, J. A., et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24, 697-702.
36. Rozen, S. and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for biologist programmers; in Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz, S. and Misener, S. (eds.), pp. 365-386, Humana Press, Totowa.
37. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., et al. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA 79, 3047-3051.
38. Schumacher, G. and Neuhaus, P. (2001) The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J. Cancer Res. Clin. Oncol. 127, 405-410.
39. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol. 46, 781-789.
40. Seegers, J. C., Aveling, M. L., Van Aswegen, C. H., Cross, M., Koch, F., et al. (1989) The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32, 797-809.
41. Soufla, G., Porichis, F., Sourvinos, G., Vassilaros, S., and Spandidos, D. A. (2005) Transcription deregulation of VEGF, FGF2, TGF-β1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett. [Epud ahead of print].
42. Swaneck, G. E. and Fishman, J. (1988) Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA 85, 7831-7835.
43. Wang, X. Y., Chen, X., Manjili, M. H., Repasky, E., Henderson, R., et al. (2003) Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res. 63, 2553-2560.
44. Ward, B. K., Mark, P. J., Ingram, D. M., Minchin, R. F., and Ratajczak, T. (1999) Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 58, 267-280.